Bulletin
Investor Alert

Dow Jones Newswires Archives | Email alerts

June 27, 2022, 2:12 a.m. EDT

Ipsen to acquire U.S.-based Epizyme for $247 million.

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Ipsen (IPN)
  • X
    Epizyme Inc. (EPZM)
  • X
    Royalty Pharma PLC (RPRX)

or Cancel Already have a watchlist? Log In

By Joshua Kirby

Ipsen said Monday that it has reached an agreement to acquire U.S. oncology drugmaker Epizyme Inc. for a cash consideration of around $247 million.

The French biopharmaceutical company /zigman2/quotes/200122335/delayed FR:IPN -1.50% will through a subsidiary offer $1.45 for each outstanding share in Epizyme /zigman2/quotes/200475462/composite EPZM -1.34% , along with a contingent value share. Epizyme’s board of directors has unanimously approved the transaction and recommended it to shareholders. The company’s largest shareholder with around 21% of the total, Royalty Pharma PLC /zigman2/quotes/205762709/composite RPRX +1.14% , has also agreed to tender its shares, Ipsen said.

The primary focus of the acquisition is the lead medicine, Tazverik (tazemetostat), a chemotherapy-free EZH2(a) inhibitor, which was granted accelerated approval by the Food and Drug Administration in 2020, Ipsen said.

The acquisition is expected to be moderately dilutive to Ipsen’s operating earnings until the end of 2024 given research-and-development costs, Ipsen said.

The transaction is expected to close by the end of the third quarter this year, dependent on regulatory approval, the company said.

Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby

/zigman2/quotes/200122335/delayed
FR : France: Euronext Paris
95.35
-1.45 -1.50%
Volume: 46,908
Aug. 12, 2022 5:35p
P/E Ratio
10.72
Dividend Yield
1.26%
Market Cap
€7.89 billion
Rev. per Employee
€513,980
loading...
/zigman2/quotes/200475462/composite
US : U.S.: Nasdaq
$ 1.47
-0.02 -1.34%
Volume: 0.00
Aug. 11, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$247.44 million
Rev. per Employee
$212,028
loading...
/zigman2/quotes/205762709/composite
US : U.S.: Nasdaq
$ 44.20
+0.50 +1.14%
Volume: 1.15M
Aug. 12, 2022 4:00p
P/E Ratio
41.17
Dividend Yield
1.72%
Market Cap
$26.76 billion
Rev. per Employee
$34.24M
loading...

This Story has 0 Comments
Be the first to comment
More News In
Dow Jones Newswires

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.